Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

FOXM1 Cistrome Predicts Breast Cancer Metastatic Outcome Better Than FOXM1 Expression Levels or Tumor Proliferation Index


ABSTRACT: This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

ORGANISM(S): Homo sapiens

SUBMITTER: Christina Yau 

PROVIDER: E-GEOD-73371 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.

Yau Christina C   Meyer Laurence L   Benz Stephen S   Vaske Charles C   Scott Gary G   Egan Brian B   Labhart Paul P   Pourmand Nader N   Benz Christopher C CC  

Breast cancer research and treatment 20151012 1


FOXM1 is a key transcription factor regulating cell cycle progression, DNA damage response, and a host of other hallmark cancer features, but the role of the FOXM1 cistrome in driving estrogen receptor-positive (ER+) versus estrogen receptor-negative (ER-) breast cancer clinical outcomes remains undefined. Chromatin immunoprecipitation sequencing (ChIP-Seq) coupled with RNA sequencing (RNA-Seq) analyses was used to identify FOXM1 target genes in breast cancer cells (MCF-7) where FOXM1 expression  ...[more]

Similar Datasets

2015-10-26 | E-GEOD-72977 | biostudies-arrayexpress
2015-10-26 | E-GEOD-73370 | biostudies-arrayexpress
2023-08-08 | E-MTAB-12195 | biostudies-arrayexpress
2010-05-18 | E-GEOD-16211 | biostudies-arrayexpress
2008-06-15 | E-GEOD-7645 | biostudies-arrayexpress
2013-12-17 | E-GEOD-26169 | biostudies-arrayexpress
2015-01-29 | E-GEOD-65398 | biostudies-arrayexpress
2021-01-04 | PXD021575 | Pride
2023-10-24 | PXD042395 | Pride
2010-05-16 | E-GEOD-19751 | biostudies-arrayexpress